Antidepressant-like effects of psoralen isolated from the seeds of Psoralea corylifolia in the mouse forced swimming test

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1109-1114

  Xu, Qun ^a   Pan, Ying ^a   Yi, Li Tao ^a   Li, Yu Cheng ^a   Mo, Shi Fu ^a,c   Jiang, Fu Xin ^a   Qiao, Chun Feng ^c   Xu, Hong Xi ^c   Lu, Xiao Bo ^b   Kong, Ling Dong ^a,b   Kung, Hsiang Fu ^b  

^a NANJING UNIVERSITY   (China)

^b Prince of Wales Hospital   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Forced swimming test; Hypothalamic pituitary adrenal axis; Psoralen; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMITRIPTYLINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; PSORALEA CORYLIFOLIA EXTRACT; PSORALEN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PLANT SEED;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DRUG EVALUATION, PRECLINICAL; HYDROXYINDOLEACETIC ACID; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PSORALEA; PSORALENS; RESTRAINT, PHYSICAL; SEROTONIN; SWIMMING;

EID: 45749140104     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1109     Document Type: Article

References (52)

1. Chaouloff F., Brain Res. Brain Res. Rev., 18, 1-32 (1993).
2. Firk C., Markus C., Rob R., J. Psychopharmacol., 21, 538-544 (2007).
3. William P., Claudine H., Marc A., Neuropsychobiology, 44, 74-77 (2001).
4. Swiergiel A. H., Leskov I. L., Dunn A. J., Behav. Brain Res., 186, 32-40 (2008).
5. Grippo A. J., Gerena D., Huang J., Kumar N., Shah M., Ughreja R., Carter C. S., Psychoneuroendocrinology, 32, 966-980 (2007).
6. Jutkiewicz E. M., Wood S. K., Houshyar H., Hsin L. W., Rice K. C., Woods J. H., Psychopharmacology, 180, 215-223 (2005).
7. Chen Y., Kong L. D., Xia X., Kung H. F., Zhang L., J. Ethnopharmacol., 96, 451-459 (2005).
8. Young E. A., Altemus M., Lopez J. F., Kocsis J. H., Schatzberg A. F., DeBattista C., Zubieta J. K., Psychoneuroendocrinology, 29, 1198-1204 (2004).
9. Post A., Ohl F., Almeida O. F., Binder E. B., Rucker M., Welt S., Binder E., Holsboer F., Sillaber I., Psychopharmacology, 180, 150-158 (2005).
10. Lowry C. A., J. Neuroendocrinol., 14, 911-923 (2002).
11. Leonard B. E., Eur. Psychiatry, 20, 302-306 (2005).
12. Li S., Wang C., Wang M. W., Murakami Y., Matsumoto K., Pharmacol. Biochem. Behav., 83, 186-193 (2006).
13. Li S., Wang C., Wang M. W., Wei L., Matsumoto K., Tang Y. Y., Life Sci., 80, 1373-1381 (2007).
14. Keeney A., Jessop D. S., Harbuz M. S., Marsden C. A., Hogg S., Blackburn-Munro R. E., J. Neuroendocrinol., 18, 330-338 (2006).
15. Liu Z. L., Zhang X. N., Zhao S. J., Zhou R. X., Di Yi Jun Yi Da Xue Xue Bao., 25, 751-752 (2005).
16. Kong L. D., Tan R. X., Woo A. Y., Cheng C. H. K., Pharmacol. Toxicol., 88, 75-80 (2001).
17. Chen Y., Wang H. D., Xia X., Kung H. F., Pan Y., Kong L. D., Phytomedicine, 14, 523-529 (2007).
18. Partonen T., Med. Hypotheses., 50, 481-482 (1998).
19. Qiao C. F., Han Q. B., Mo S. F., Song J. Z., Xu L. J., Chen S. L., Yang D. J., Kong L. D., Kung H. F., Xu H. X., Chem. Pharm. Bull., 54, 714-716 (2006).
20. Porsolt R. D., Bertin A., Jalfre M., Archives Internationales de Pharmacodynamie et de Th'erapie, 229, 327-336 (1977).
21. Cryan J. F., Lucki I., J. Pharmacol. Exp. Ther., 295, 1120-1126 (2000).
22. Detke M. J., Rickels M., Lucki I., Psychopharmacology, 121, 66-72 (1995).
23. Lucki I., Behav. Pharmacol., 18, 523-532 (1997).
24. Curzon G., Green A. R., Br. J. Pharmacol., 39, 653-655 (1970).
25. Welch B. L., Welch A. S., Proc. Natl. Acad. Sci. U.S.A., 64, 100-107 (1969).
26. Detke M. J., Johnson J., Lucki I., Exp. Clin. Psychopharmacol., 5, 107-112 (1997).
27. Nielsen D. M., Carey G. J., Gold L. H., Eur. J. Pharmacol., 499, 135-146 (2004).
28. Connor T. J., Kelliher P., Shen Y., Harkin A., Kelly J. P., Leonard B. E., Biochem. Behav., 65, 591-597 (2000).
29. Guo W., Todd K., Bourin M., Hascoet M., Kouadio F., Pharmacol. Biochem. Behav., 54, 725-730 (1996).
30. Benoit P. D., Franck C., Michel B., Petit-Demouliere B, Chenu F., Bowin M., Psychopharmacology (Berl.), 177, 245-255 (2005).
31. Kirby L. G., Lucki I., J. Pharmacol. Exp. Ther., 282, 967-976 (1997).
32. Wang Y. M., Kong L. D., Chen Y. M., Phytother. Res., 19, 526-529 (2005).
33. Veenema A. H., Cremers T. I. F. H., Jongsma M. E., Psychopharmacology, 178, 151-160 (2005).
34. Haier R. J., Buchsbaum M. S., DeMet E., Wu J., Neuropsychobiology, 20, 62-66 (1988).
35. Tichomirowa M. A., Keck M. E., Schneider H. J., Paez-Pereda M., Renner U., Holsboer F., Stalla G. K., J. Endocrinol. Invest., 28, 89-99 (2005).
36. Barden N., J. Psychiatry Neurosci., 29, 185-193 (2004).
37. Holsboer F., Barden N., Endocr. Rev., 17, 187-205 (1996).
38. Kirschbaum C., Hellhammer D. H., Psychoneuroendocrinology, 19, 313-333 (1994).
39. van Heeringen K., Audenaert K., de Van W., Verstraete L. A., J. Affect. Disord., 60, 181-189 (2000).
40. De Groote L., Penalva R. G., Flachskamm C., Reul J. M. H. M., Linthorst A. C. E., J. Neurochem., 94, 45-56 (2005).
41. Ayensu W. K., Pucilowski O., Mason G. A., Overstreet D. H., Rezvani A. H., Janowsky D. S., Physiol. Behav., 57, 165-169 (1995).
42. Ducrocq F., Vaiva G., Encephale., 31, 212-226 (2005).
43. Holtzheimer P. E., Nemeroff C. B., NeuroRx., 3, 42-56 (2006).
44. Hall F. S., Sundstrom J. M., Lerner J., Pert A., Pharmacol. Biochem. Behav., 69, 629-634 (2001).
45. Tataroglu O., Aksoy A., Yilmaz A., Canbeyli R., Brain Res., 1001, 118-124 (2004).
46. Cryan J., Valentino R., Lucki I., Neurosci. Biobehav. Rev., 29, 547-569 (2005).
47. Pan Y., Kong L. D., Xia X., Zhang W. Y., Xia Z. H., Jiang F. X., Pharmacol. Biochem. Behav., 82, 686-694 (2005).
48. Slawecki C. J., Thorsell A. K., ElKhoury A., Mathe A. A., Ehlers C. L., Neuropeptides, 39, 369-377 (2005).
49. Racca S., Spaccamiglio A., Esculapio P., Abbadessa G., Cangemi L., DiCarlo F., Portaleone P., Pharmacol. Biochem. Behav., 81, 894-900 (2005).
50. Andrade S., Silveira S. L., Gomez R., Barros H. M. T., Ribeiro M. F., Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 613-621 (2007).
51. Heuser I. J., Schweiger U., Gotthardt U., Schmider J., Lammers C. H., Dettling M., Yassouridis A., Holsboer F., Am. J. Psych., 153, 93-99 (1996).
52. Price M. L., Kirby L. G., Valentino R. J., Lucki I., Psychopharmacology, 162, 406-414 (2002).